GlaxoSmithKline

GSK’s experimental HIV drug trial produces positive results

GSK’s experimental HIV drug trial produces positive results

U.K.-based GlaxoSmithKline PLC’s ViiV Healthcare on Tuesday announced positive results for its phase-three trial of its experimental HIV drug in a dual-drug regimen.

News: 
Location: 
Company: 

GlaxoSmithKline seeking Approval for Malaria Vaccine

GlaxoSmithKline seeking Approval for Malaria Vaccine

In order to save lives of many people from one of the world's deadliest diseases, regulators have been urged by Britain's biggest drug manufacturer to approve a vaccine developed to target malaria. GlaxoSmithKline has been working towards the development of an experimental treatment which has a great potential to become the world's first malaria vaccination shot.

The group - recorded double-digit loss in revenue and profits in the first half of 2014 - has filed an application seeking approval for sale of the RTS,S vaccine exclusively outside the European Union.

News: 
Location: 
Company: 

Singapore to Check Tamiflu after UK based Cochrane Collaboration Report on Tamiflu

Singapore to Check Tamiflu after UK based Cochrane Collaboration Report on Tamif

The Ministry of Health in Singapore has planned to start an investigation regarding the positive impact of Roche AG’s Tamiflu and GSK’s Relenza in controlling flu. UK based non-profit organization Cochrane Collaboration had reported earlier this week that tamiflu and relenza were not found effective after their reviewed 170,000 pages of clinical trial data.

Effectiveness of Stockpiled Tamiflu and Relenza Questioned by UK based Research Organization

Effectiveness of Stockpiled Tamiflu and Relenza Questioned

The anti-flu drugs stockpiled by governments across the world including tamiful and relenza, might do more harm than offering benefit to individuals. As per the study conducted by UK based nonprofit research organization Cochrane Collaboration, the drugs tamiflu and relenza, stockpiled by governments to fight influenza outbreaks might cause harm after their team reviewed 170,000 pages of clinical trial records. Cochrane Collaboration has urged health department to carry out a detailed review about the role of flu drugs in controlling the spread of influenza.

Location: 
Laboratories: 

FDA Probes Tampering of 20 Bottles of Glaxo’s Drug, Alli

FDA Probes Tampering of 20 Bottles of Glaxo’s Drug, Alli

The U.S. Food and Drug Administration (FDA) agency is investigating the reason behind the tampering of 20 bottles of Alli, GlaxoSmithKline Plc's weight-loss drug sold in United States. The Company reported that five lots of the drug sold in stores in seven mostly Southern states were dissimilar in shapes and color compared with actual color of the drug which is turquoise.

The drug has been approved for use without a prescription for overweight adults along with a low-fat diet.

News: 
Company: 

GSK Shares Disappointment on Failure of its Lung Cancer Treatment in Phase III Trial

GSK Shares Disappointment on Failure of its Lung Cancer Treatment in Phase III T

GlaxoSmithKline Plc has reported that its experimental lung cancer treatment, MAGE-A3 antigen-specific cancer immunotherapeutic, failed in its phase III clinical trial to treat lung cancer. The company said that the drug failed in treating patients with non-small cell lung cancer (NSCLC) clinical trial.

Location: 
Person: 
Company: 

GSK 722LA could be Game Changer in HIV Prevention Efforts, Say Researchers

GSK 722LA could be Game Changer in HIV Prevention Efforts, Say Researchers

An experimental drug GSK 744LA could prove successful in treating repeated intrarectal infections with the deadly SHIV virus in monkeys, may also be used to protect AIDS infection in humans for three months, said US researchers. David Ho, researcher at the Aaron Diamond AIDS Research Center in New York, said that the drug could be maintained for three to four months in humans at adequate levels to keep the safe against infection.

Company: 

European Regulators Approve Albiglutide

European Regulators Approve Albiglutide

A once-weekly injectable glucagonlike peptide 1 (GLP 1) diabetes drug, albiglutide, has received green signal from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), said GlaxoSmithKline. This drug has been approved for use as monotherapy in patients with Type 2 diabetes.

Location: 
Company: 

RotaTeq and Rotarix Termed Safer Vaccines for Rotavirus

RotaTeq and Rotarix Termed Safer Vaccines for Rotavirus

New study published in NEJM has found GlaxoSmithKline’s Rotarix and Merck AG’s RotaTeq as safer vaccines for deadly rotavirus which impacts young kids in developing and poor nations. The first rotavirus vaccine was pulled from the market due to higher number of intussusception cases. CDC in United States has found the two new vaccines much safer, with less side effects, based on 1.5 million doses administered.

Laboratories: 
News: 
Company: 

FDA Approves GSK Application to market Melanoma Drug Combination

FDA Approves GSK Application to market Melanoma Drug Combination

GlaxoSmithKline (GSK) has won approval from the US Food and Drug Administration (FDA) to market melanoma drug combination in US market. The drug maker has received green signal to make melanoma drug by combining two drugs Tafinlar and Mekinist or trametinib.

Laboratories: 
Company: 

Popular Stories

Harley-Davidson to turn 8 Dyna motorbikes into new Softail bikes

Betting big on cruisers, the luxury motorcycle... Read More

Uber’s net loss declines as ride bookings grow

Uber Technologies reported lower loss by nearly 9... Read More

Samsung Galaxy Note 8 facing challenges on multiple fronts

The Samsung Galaxy Note 8 is facing an increasingly... Read More

Leaked reports reveal more about new BMW M5

Luxury carmaker BMW’s next-generation M5 car will... Read More